Arrow Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $263K | Sell |
4,331
-920
| -18% | -$53.6K | 0.03% | 143 |
|
|
2025
Q4 | $283K | Sell |
5,251
-294
| -5% | -$14.1K | 0.03% | 141 |
|
|
2025
Q3 | $250K | Sell |
5,545
-1,074
| -16% | -$50.2K | 0.03% | 145 |
|
|
2025
Q2 | $306K | Sell |
6,619
-1,025
| -13% | -$50.3K | 0.03% | 139 |
|
|
2025
Q1 | $466K | Sell |
7,644
-24
| -0.3% | -$1.4K | 0.05% | 124 |
|
|
2024
Q4 | $434K | Sell |
7,668
-1,733
| -18% | -$96.8K | 0.04% | 137 |
|
|
2024
Q3 | $486K | Sell |
9,401
-15,468
| -62% | -$726K | 0.05% | 132 |
|
|
2024
Q2 | $1.03M | Sell |
24,869
-16,552
| -40% | -$741K | 0.1% | 103 |
|
|
2024
Q1 | $2.25M | Buy |
41,421
+1,637
| +4% | +$83.4K | 0.22% | 72 |
|
|
2023
Q4 | $2.04M | Buy |
39,784
+412
| +1% | +$21.6K | 0.21% | 71 |
|
|
2023
Q3 | $2.29M | Sell |
39,372
-374
| -0.9% | -$22.9K | 0.27% | 69 |
|
|
2023
Q2 | $2.54M | Buy |
39,746
+140
| +0.4% | +$9.39K | 0.31% | 72 |
|
|
2023
Q1 | $2.75M | Buy |
39,606
+468
| +1% | +$33K | 0.36% | 65 |
|
|
2022
Q4 | $2.82M | Sell |
39,138
-151
| -0.4% | -$11.4K | 0.38% | 62 |
|
|
2022
Q3 | $2.79M | Sell |
39,289
-51
| -0.1% | -$3.7K | 0.41% | 56 |
|
|
2022
Q2 | $3.03M | Sell |
39,340
-325
| -0.8% | -$24.8K | 0.41% | 56 |
|
|
2022
Q1 | $2.9M | Buy |
39,665
+1,145
| +3% | +$76.9K | 0.35% | 62 |
|
|
2021
Q4 | $2.4M | Buy |
38,520
+4,317
| +13% | +$253K | 0.28% | 69 |
|
|
2021
Q3 | $2.02M | Sell |
34,203
-298
| -0.9% | -$19.6K | 0.26% | 67 |
|
|
2021
Q2 | $2.31M | Sell |
34,501
-8,097
| -19% | -$528K | 0.29% | 62 |
|
|
2021
Q1 | $2.69M | Sell |
42,598
-273
| -0.6% | -$17K | 0.36% | 55 |
|
|
2020
Q4 | $2.66M | Sell |
42,871
-376
| -0.9% | -$23.1K | 0.52% | 51 |
|
|
2020
Q3 | $2.61M | Sell |
43,247
-225
| -0.5% | -$13.5K | 0.55% | 49 |
|
|
2020
Q2 | $2.56M | Sell |
43,472
-614
| -1% | -$36.7K | 0.56% | 47 |
|
|
2020
Q1 | $2.46M | Buy |
44,086
+8
| +0% | +$489 | 0.58% | 42 |
|
|
2019
Q4 | $2.83M | Buy |
44,078
+10,852
| +33% | +$621K | 0.55% | 48 |
|
|
2019
Q3 | $1.69M | Sell |
33,226
-510
| -2% | -$24K | 0.35% | 67 |
|
|
2019
Q2 | $1.53M | Buy |
33,736
+1,192
| +4% | +$55.5K | 0.33% | 70 |
|
|
2019
Q1 | $1.55M | Buy |
32,544
+1,160
| +4% | +$57.8K | 0.36% | 69 |
|
|
2018
Q4 | $1.63M | Buy |
31,384
+2,175
| +7% | +$117K | 0.42% | 64 |
|
|
2018
Q3 | $1.81M | Buy |
29,209
+121
| +0.4% | +$7.18K | 0.38% | 66 |
|
|
2018
Q2 | $1.61M | Sell |
29,088
-565
| -2% | -$30.5K | 0.36% | 71 |
|
|
2018
Q1 | $1.88M | Sell |
29,653
-727
| -2% | -$46.8K | 0.43% | 62 |
|
|
2017
Q4 | $1.86M | Sell |
30,380
-500
| -2% | -$31.3K | 0.43% | 64 |
|
|
2017
Q3 | $1.97M | Sell |
30,880
-3,255
| -10% | -$190K | 0.47% | 59 |
|
|
2017
Q2 | $1.9M | Sell |
34,135
-15,828
| -32% | -$861K | 0.46% | 63 |
|
|
2017
Q1 | $2.72M | Sell |
49,963
-795
| -2% | -$43.6K | 0.66% | 44 |
|
|
2016
Q4 | $2.97M | Sell |
50,758
-144
| -0.3% | -$7.87K | 0.74% | 37 |
|
|
2016
Q3 | $2.74M | Sell |
50,902
-2,951
| -5% | -$190K | 0.7% | 41 |
|
|
2016
Q2 | $3.96M | Buy |
53,853
+89
| +0.2% | +$6.29K | 1.03% | 25 |
|
|
2016
Q1 | $3.44M | Buy |
53,764
+5,646
| +12% | +$356K | 0.91% | 32 |
|
|
2015
Q4 | $3.31M | Buy |
48,118
+9,646
| +25% | +$637K | 0.88% | 36 |
|
|
2015
Q3 | $2.28M | Buy |
38,472
+239
| +0.6% | +$15.2K | 0.65% | 51 |
|
|
2015
Q2 | $2.54M | Buy |
38,233
+427
| +1% | +$28.1K | 0.69% | 44 |
|
|
2015
Q1 | $2.44M | Buy |
37,806
+171
| +0.5% | +$10.7K | 0.66% | 52 |
|
|
2014
Q4 | $2.22M | Sell |
37,635
-820
| -2% | -$46.2K | 0.61% | 58 |
|
|
2014
Q3 | $1.97M | Buy |
38,455
+1,673
| +5% | +$83.6K | 0.55% | 60 |
|
|
2014
Q2 | $1.78M | Buy |
36,782
+440
| +1% | +$21.7K | 0.48% | 73 |
|
|
2014
Q1 | $1.89M | Sell |
36,342
-5,248
| -13% | -$279K | 0.54% | 66 |
|
|
2013
Q4 | $2.21M | Sell |
41,590
-400
| -1% | -$20.4K | 0.63% | 57 |
|
|
2013
Q3 | $1.94M | Sell |
41,990
-1,450
| -3% | -$63.6K | 0.6% | 57 |
|
|
2013
Q2 | $1.94M | Buy |
+43,440
| New | +$1.89M | 0.62% | 52 |
|
Other funds holding BMY
VCM
VPM
Arrow Financial's BMY Position: Q1 2026 in Review
Arrow Financial reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q1 2026, selling an estimated $53.6K and leaving 4,331 shares worth $263K. The position accounts for 0.03% of the portfolio, ranked #143.
Arrow Financial first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.96M in Q2 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Arrow Financial held 4,331 shares of Bristol-Myers Squibb worth $263K as of Q1 2026.
- Arrow Financial sold 920 Bristol-Myers Squibb shares in Q1 2026, an estimated $53.6K.
- Bristol-Myers Squibb made up 0.03% of Arrow Financial's portfolio in Q1 2026, its #143 holding.
- Arrow Financial first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Arrow Financial's Bristol-Myers Squibb position peaked at $3.96M in Q2 2016.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.